GLUT overexpression in prostate cancer and other tumors is well studied, and an elevated expression of hypoxia-inducible factor 1 leads to the expression of GLUT1 and GLUT3 that upregulate glucose uptake and drives glucose to the glycolytic pathway [14,15]. The gene discussed is SLC2A1; the disease is prostate cancer.